Mendelian randomization analysis of the effect of maternal homocysteine during pregnancy, as represented by maternal MTHFR C677T genotype, on birth weight

J Epidemiol. 2013 Sep 5;23(5):371-5. doi: 10.2188/jea.je20120219. Epub 2013 Jul 13.

Abstract

Background: We used Mendelian randomization analysis to investigate the causal relationship between maternal homocysteine level, as represented by maternal methylenetetrahydrofolate reductase (MTHFR) C677T genotype, with the birth weight of offspring.

Methods: We recruited women at 24 to 28 weeks' gestation who visited Ewha Womans University Hospital for prenatal care during the period from August 2001 to December 2003. A total of 473 newborns with a gestational age of at least 37 weeks were analyzed in this study. We excluded twin births and children of women with a history of gestational diabetes, gestational hypertension, or chronic renal disease. The association of maternal homocysteine concentration with the birth weight of infants was analyzed using 2-stage regression.

Results: MTHFR C677T genotype showed a dose-response association with homocysteine concentration for each additional T allele (Ptrend < 0.01). Birth weight decreased from 120 to 130 grams as maternal homocysteine level increased, while controlling for confounding factors; however, the association was of marginal significance (P = 0.06).

Conclusions: Our results suggest an adverse relationship between maternal homocysteine level and birth weight. A reduction in homocysteine levels might positively affect birth outcomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Birth Weight*
  • Female
  • Genotype
  • Homocysteine / blood*
  • Humans
  • Infant, Newborn
  • Male
  • Mendelian Randomization Analysis
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Republic of Korea

Substances

  • Homocysteine
  • Methylenetetrahydrofolate Reductase (NADPH2)